These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19836380)

  • 1. Cadherins as novel targets for anti-cancer therapy.
    Blaschuk OW; Devemy E
    Eur J Pharmacol; 2009 Dec; 625(1-3):195-8. PubMed ID: 19836380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel peptide mimetic small molecules of the HAV motif in N-cadherin inhibit N-cadherin-mediated neurite outgrowth and cell adhesion.
    Burden-Gulley SM; Gates TJ; Craig SE; Lou SF; Oblander SA; Howell S; Gupta M; Brady-Kalnay SM
    Peptides; 2009 Dec; 30(12):2380-7. PubMed ID: 19765627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug evaluation: ADH-1, an N-cadherin antagonist targeting cancer vascularization.
    Kelland L
    Curr Opin Mol Ther; 2007 Feb; 9(1):86-91. PubMed ID: 17330406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-cadherin as an invasion promoter: a novel target for antitumor therapy?
    Cavallaro U
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1274-8. PubMed ID: 15648948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel N-cadherin antagonist.
    Devemy E; Blaschuk OW
    Peptides; 2008 Nov; 29(11):1853-61. PubMed ID: 18655820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
    Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
    J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
    Labelle M; Schnittler HJ; Aust DE; Friedrich K; Baretton G; Vestweber D; Breier G
    Cancer Res; 2008 Mar; 68(5):1388-97. PubMed ID: 18316602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.
    Nam JS; Ino Y; Sakamoto M; Hirohashi S
    Clin Cancer Res; 2002 Jul; 8(7):2430-6. PubMed ID: 12114449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion molecules as targets for cancer therapy.
    Huang YW; Baluna R; Vitetta ES
    Histol Histopathol; 1997 Apr; 12(2):467-77. PubMed ID: 9151136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-scale modelling of cancer cell intravasation: the role of cadherins in metastasis.
    Ramis-Conde I; Chaplain MA; Anderson AR; Drasdo D
    Phys Biol; 2009 Mar; 6(1):016008. PubMed ID: 19321920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cadherins in the transendothelial migration of melanoma cells in culture.
    Sandig M; Voura EB; Kalnins VI; Siu CH
    Cell Motil Cytoskeleton; 1997; 38(4):351-64. PubMed ID: 9415377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
    Hakomori S
    Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadherin superfamily of adhesion molecules in primary lung cancer.
    Charalabopoulos K; Gogali A; Kostoula OK; Constantopoulos SH
    Exp Oncol; 2004 Dec; 26(4):256-60. PubMed ID: 15627055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-cadherin antagonists as oncology therapeutics.
    Blaschuk OW
    Philos Trans R Soc Lond B Biol Sci; 2015 Feb; 370(1661):20140039. PubMed ID: 25533096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INP, a novel N-cadherin antagonist targeted to the amino acids that flank the HAV motif.
    Williams EJ; Williams G; Gour B; Blaschuk O; Doherty P
    Mol Cell Neurosci; 2000 May; 15(5):456-64. PubMed ID: 10833302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
    Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
    Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling.
    Derycke LD; Bracke ME
    Int J Dev Biol; 2004; 48(5-6):463-76. PubMed ID: 15349821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrins, cadherins, and catenins: molecular cross-talk in cancer cells.
    Pignatelli M
    J Pathol; 1998 Sep; 186(1):1-2. PubMed ID: 9875132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel dual E- and N-cadherin antagonist.
    Devemy E; Blaschuk OW
    Peptides; 2009 Aug; 30(8):1539-47. PubMed ID: 19465078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.